A Road Less Followed

Our story is unique in the world of life sciences investing. We are a privately held biotechnology company located at the HudsonAlpha Institute of Biotechnology in Huntsville, Alabama. Not Boston or San Francisco. And unlike the majority of biotech companies, we have not been funded by traditional venture capital firms.

Since our founding in 2007, we have been funded entirely by our founders and their friends in the Huntsville life sciences and technology communities. These investors followed the team to Serina after the success (exit via acquisition by Nektar Therapeutics) of the their prior company, Shearwater Polymers.

At Shearwater, Serina co-founders Harris and Bentley developed the first-generation of PEGylated drugs.  The PEG platform has enabled 19 FDA approved PEGylated drugs that have since generated over $140B in cumulative sales, not including the mRNA COVID vaccines.

Serina was founded to create a next generation polymer therapeutic that addresses the limitations of PEG….. enabling new treatment paradigms for patients suffering from some of the world’s most challenging diseases.

Learn more


Serina Therapeutics and AgeX Therapeutics enter into Merger Agreement Download PDF